Signals, Powered By EquityPandit
Suven Life Science has got grant of one patent each in 5 nations including China and Israel, for a drug which is used in the treatment of neurodegenerative diseases.
“one product patent from China, one product patent from Israel, one product patent from Mexico, one product patent from Singapore and one product patent from Sri Lanka corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases,” the company said in a BSE filing.
Venkat Jasti, Suven Life Science CEO said, “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the central nervous system (CNS) arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.”
